Nanotechnological and Molecular Advances in Point-of-care and Healthcare Settings - Genetic TOE

USD 1,500.00

* Required Fields

USD 1,500.00


Be the first to review this product

This edition of Genetic TOE depicts nanotechnological and molecular advances in point-of-care and healthcare settings. The corresponding patent scenario is depicted, along with the industry interactions.The Genetic TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness cluster

Table of Contents

Nanotechnological and Molecular Advances in Point-of-care and Healthcare Settings - Genetic TOETechnology ProfilesNovel Nanotechnological Platform for Point-of-care Diagnostics Improving Sensitivity for Automated Immunoanalyzers Enhancing Pathogen Detection in Lateral Flow AssaysBreakthrough Biosensing Platform for Diabetes ManagementAppendixPatent ScenarioPatent Scenario (continued)Industry Interactions

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.